-
Faiez Zannad
MD, PhD Professor of Therapeutics and Cardiology Director, Clinical Investigation Center INSERM Head, Heart Failure and Hypertension Unit Department of Cardiology, CHU and Univers (...)
►Read more...
<<
-
Welcome Introduction Symposium
-
Aldosterone and mineralocortoid receptors: expanding views from the kidney to the cardiovascular system.
-
Overexpression of the mineralocorticoid receptors: pathophysiological consequences
-
Questions and Answers
-
Mineralocorticoid receptor blockade: how experimental evidence supports the clinical benefit
-
Questions and Answers
-
The proximate cause of heart failure: models, remodeling, and re-remodeling
-
Questions and Answers
-
After RALES, the journey continues
-
Questions and Answers
-
Efficacy of spironolactone in dogs with naturally occurring Myxomatous Mitral Valve Disease. (part I)
-
Efficacy of spironolactone in dogs with naturally occurring Myxomatous Mitral Valve Disease. (part II)
-
Principles of survival analysis illustrated by CEVA’s spironolactone trials
-
Questions and Answers
-
Current clinical status and future directions for biomarkers in heart failure
-
Questions and Answers
-
Conclusion Symposium
-
TEST
>>
